Consonance Capital Management LP Ani Pharmaceuticals Inc Transaction History

Consonance Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$55.65 - $79.83 $7.95 Million - $11.4 Million	-142,943 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$56.98 - $72.41 $1,994 - $2,534	-35 Reduced 0.02%	142,943 $8.32 Million
Q4 2017 Feb 14, 2018	SELL	$53.3 - $74.56 $1,332 - $1,864	-25 Reduced 0.02%	142,978 $9.22 Million
Q3 2017 Nov 14, 2017	BUY	$43.46 - $52.49 $6.21 Million - $7.51 Million	143,003	143,003 $7.51 Million

209

16.4M

24K

7.7K

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $1.04B
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

Get notified when there are updates to the investment portfolio of Consonance Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Consonance Capital Management LP with notifications on news.